Clinical trial
The Efficacy of Risedronate in Prevention of Bone Loss in Patients Receiving…
NCT00372372 · Tuen Mun Hospital, Other · Completed
Key facts
| NCT number | NCT00372372 |
|---|---|
| Title | The Efficacy of Risedronate in Prevention of Bone Loss in Patients Receiving High Dose Corticosteroid Treatment |
| Lead sponsor | Tuen Mun Hospital, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Osteoporosis |
| Intervention type | Drug |
| Interventions | risedronate |
| Enrollment | 120 |
| Start date | Jan 1, 2004 |
| Completion | Apr 1, 2007 |
| First posted | Sep 6, 2006 |
| Last update posted | Sep 28, 2007 |
| Countries | China |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: